How does EGA contribute to personalized medicine in cancer treatment?
Personalized medicine aims to tailor treatment to the individual characteristics of each patient. The EGA contributes to this by providing access to genomic data that can be used to identify genetic mutations and biomarkers associated with specific cancer types. This information can help in developing targeted therapies and predicting patient response to treatment, ultimately improving outcomes and reducing side effects.
